The clinical application of fluoresence in situ hybridization in diagnosis of urothelial bladder cancer

YUAN xiao-liang,GAN Wei-dong,YAO Lin-fang,YAN Xiang,LIU Tie-shi,QU Feng,ZHAO Xiao-zhi,YANG Rong,LI Xiao-gong,ZHANG Gu-tian,ZHANG Shi-wei,GUO Hong-qian
DOI: https://doi.org/10.3877/cma.j.issn.1674-3253.2012.01.014
2012-01-01
Abstract:Objective To evaluate the value of fluorescence in situ hybridization (FISH) in diagnosis of urothelial bladder cancer. Methods Twenty specimens were obtained from healthy people. Using directly labeled DNA probes of the 3rd, 7th, 17th and P16 dot at 9th chromosome to detect the exfoliated urothelial cells in the urine. And get the threshold value of healthy adult. Fresh urine samples from 158 patients who were suspected of bladder carcinoma were collected and examined by cytology and fish simultaneously before cystoscopy. The sensitivity and specificity of FISH and cytology were analyzed. Results The sensitivity of FISH and cytology was 84.8% and 43.8%. The sensitivity of FISH was prior to that of cytology (P<0.05), the specificity of FISH and cytology was 89.1% and 87.0%(P>0.05). In different tumor pathologic grade and clinical stuns, FISH got a higher sensitivity than cytology, which gradually increased following with increasing tumor pathologic grade(P<0.05). Conclusions FISH has high sensitivity and specificity in diagnosing urothelial bladder cancer, it may be a new method to screen and diagnose bladder cancer in Chinese people in the future.
What problem does this paper attempt to address?